Skip to content

MC1R Mutations Associated With Red Hair and Perioperative Anesthesia Complications

The Presence of Red Hair Associated MC1R Mutations and the Incidence of Perioperative Anesthesia Complications: A Cohort Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07815431
Acronym
MARPAC
Enrollment
100000
Registered
2026-09-11
Start date
2026-09-01
Completion date
2026-12-01
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia Complication, Melanocortin 1 Receptor, Perioperative Adverse Events, Red Hair

Keywords

Red hair, Anesthesia, Surgery, Perioperative complications, Adverse events, Melanocortin 1 receptor mutation, MC1R

Brief summary

The study aims to investigate whether patients with Melanocortin-1 receptor (MC1R) mutations, associated with red hair, or having a red hair phenotype, have a higher incidence of anesthesia-related perioperative complications. Genomic data from patients that have undergone a surgical or medical procedure, requiring an anesthetic management are extracted from two cohorts - a Swedish (Merged Anaesthesia and Intensive Care Cohort in Sweden (MAICS)), and a British (UK Biobank UKBB)), and linked to relevant healthcare registries. The outcome variables studied are statistically adjusted for age, gender, timing of procedure during the study period, and socioeconomic factors.

Detailed description

Background Perioperative complications may be associated with both suffering for the affected individuals, and a high cost for society. Available means for identifying individuals at risk should be considered. Objective To investigate whether patients with MC1R variants (Asp84Glu, Arg142His Arg151Cys, Tyr152Ochre, Ile155Thr, Arg160Trp, Arg213Trp, Asp294His, or Arg306His) associated with red hair, or having a red hair phenotype have an increased incidence of anesthesia related perioperative complications. Method This is a retrospective registry-based study including patients from one Swedish cohort (MAICS), and one British cohort (UKBB). MAICS is aggregation of four different cohorts; PronMed, Epihealth, Simpler, and the Swedish Twin Registry (STR). The Patients are selected from the Swedish National Patient Registry (NPR), and the Hospital Episode Statistics (HES)/NHS England using surgical and medical procedure codes known for requiring an anesthetic management in the form of general anesthesia, spinal/epidural anesthesia or regional anesthesia. Eligible patients are associated with genotype data, and stratified into either homozygote/compound heterozygote, heterozygote, or wildtype to be able to assess whether a dose-response relationship exists between the different levels of exposures. From UKBB, a separate analysis of the association between red hair phenotype and perioperative complications is performed. Outcome ascertainment, and the defining of cases and non-cases, is perfomed using healthcare linkage to Swedish Perioperative Registry (SPOR), Swedish Intensive Care Register (SIR), National cause of death registry (DORS), Statistics Sweden, and UKBB. The results will be analyzed using a statistical mixed effects model, adjusted for age, sex, timing of surgery during the study period, and socioeconomic factors. The results of the genotype analysis from the two cohorts will be meta-analyzed.

Interventions

None listed

Sponsors

Uppsala University
Lead SponsorOTHER
County Council of Gavleborg
CollaboratorOTHER
Dalarna County Council, Sweden
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* A qualifying surgical procedure requiring specified anesthetic management. * A qualifying medical procedure requiring specified anesthetic management. * Caucasian origin.

Exclusion criteria

* None specified.

Design outcomes

Primary

MeasureTime frameDescription
Serious adverse events occurring after a surgical, or medical procedure requiring anesthetic.Days 30 after a qualifying procedure.A composite of adverse events consisting of Death, Unplanned ICU-admission, Myocardial arrest (ICD10: I46), Myocardial infarction (ICD10: I21-22), Pneumonia (ICD10: J13-16, J18, J85, J86, A481), and Anaphylaxis (ICD10: T782, T805, T886) Up until 30 days after the procedure.

Secondary

MeasureTime frameDescription
Serious adverse events occurring after a surgical, or medical procedure requiring anesthetic.Days 30 after a qualifying procedure.The variables in the composite outcome analyzed one by one.
Adverse events registered at the post anesthesia care unit (PACU)Hours 24 after a qualifying procedure.Tachy-/bradycardia, arrythmia, angina, heart failure, hypo-/hypertension, and unexpected bleeding registered in the Swedish Perioperative Register (SPOR) from patients originating from the Swedish cohort.

Countries

Sweden

Contacts

CONTACTMiklós Lipcsey, MD, PhD
miklos.lipcsey@uu.se0046 18 611 0000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026